期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
以腋下淋巴结肿大为首发表现的系统性红斑狼疮1例分析 被引量:1
1
作者 毛跃 田洪淑 +1 位作者 张碧霞 赵德军 《中国误诊学杂志》 CAS 2007年第25期6168-6168,共1页
关键词 红斑狼疮 系统性/诊断 淋巴结肿大/诊断
下载PDF
First endoscopic procedure for diagnosis and staging of mediastinal lymphadenopathy
2
作者 Kay-Leong Khoo Khek-Yu Ho +2 位作者 Christopher Jen-Lock Khor Barbro Nilsson Tow-Keang Lim 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第48期6096-6101,共6页
AIM:To compare a first diagnostic procedure of transbronchial needle aspiration(TBNA)with selection of endoscopic ultrasound-guided fine-needle aspiration(EUS-FNA)or TBNA for mediastinal lymphadenopathy.METHODS:Sixty-... AIM:To compare a first diagnostic procedure of transbronchial needle aspiration(TBNA)with selection of endoscopic ultrasound-guided fine-needle aspiration(EUS-FNA)or TBNA for mediastinal lymphadenopathy.METHODS:Sixty-eight consecutive patients with mediastinal lymphadenopathy on computed tomography(CT),who required cytopathological diagnosis,were recruited.The first 34 underwent a sequential approach in which TBNA was performed first,followed by EUS-FNA if TBNA was unrevealing.The next 34 underwent a selective approach where either TBNA or EUS-FNA was selected as the first procedure based on the CT findings.RESULTS:The diagnostic yield of TBNA as the first diagnostic procedure in the sequential approach was 62%.In the selective approach,the diagnostic yield of the first procedure was 71%.There was no significant difference in the overall diagnostic yield,but there were significantly fewer combined procedures with the selective approach.CONCLUSION:Selecting either EUS-FNA or TBNA as the first diagnostic procedure achieved a comparable diagnostic yield with significantly fewer procedures than performing TBNA first in all patients. 展开更多
关键词 Aspiration biopsy Needle biopsy ENDOSCOPY Ultrasound MEDIASTINUM LYMPHADENOPATHY Lung neoplasms DIAGNOSIS Neoplasms staging
下载PDF
Overlooked diagnosis of Castleman disease within the abdomen
3
作者 Yang Xinwei Li Zhe Liu Kai Liu Hu Fu Xiaohui Yang Jiahe Wu Mengchao 《Journal of Medical Colleges of PLA(China)》 CAS 2010年第3期187-192,共6页
Castleman disease is a rare disorder of the lymphoid tissue,characterized by lymph node enlargement with distinctive histologic features.It usually occurs within the mediastinum and rarely within the abdomen.It is usu... Castleman disease is a rare disorder of the lymphoid tissue,characterized by lymph node enlargement with distinctive histologic features.It usually occurs within the mediastinum and rarely within the abdomen.It is usually indistinguishable from other mediastinal and hilar masses before determining a surgical approach.We present two cases of Castleman disease within the abdomen mimicking a neoplasm. 展开更多
关键词 Castleman disease Lymphoproliferative disorder Abdominal neoplasm DIAGNOSIS PROGNOSIS
下载PDF
Endostar combined GC in the treatment of advanced non-small cell lung cancer:a case report
4
作者 Changlin Zhao Junbo Yuan Ganlu Zhang Fangjuan Hu Xi Yu Mingzhi Ren Wenjun Zhang 《The Chinese-German Journal of Clinical Oncology》 CAS 2011年第9期551-553,共3页
A 43-year-old female with a 3-month history of paroxysmal irritating cough presented progressive chest tightness and shortness of breath.Laboratory data showed elevated carcino-embryonic antigen(CEA).Further imaging s... A 43-year-old female with a 3-month history of paroxysmal irritating cough presented progressive chest tightness and shortness of breath.Laboratory data showed elevated carcino-embryonic antigen(CEA).Further imaging studies revealed a soft tissue mass shadow was in right middle lobe lung with mediastinal and sub-carinal lymph nodes enlarged.Biopsy diagnosis:moderately and poorly differentiated adenocarcinoma of the lung.Clinical diagnosis:central non-small cell lung cancer(NSCLC) of right middle lobe(CIVT4N2M1),lung adenocarcinoma G2-3,malignant pleural effusion,pericardial effusion,hilar and mediastina lymph node metastases.After 4 cycles of endostar plus GC therapy,imaging studies revealed showed soft tissue mass in right middle lobe disappeared,and evaluation of short-term result was complete remission(CR).PFS has been seven months till now.Therefore,this report provided strong evidence that endostatin combined GC treatment for advanced NSCLC is safe and effective,which can prolong survival and improve quality of life. 展开更多
关键词 lung tumor non-small cell lung cancer(NSCLC) advanced ENDOSTAR CHEMOTHERAPY
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部